Meta-analysis of C-Reactive Protein and Risk of Angina Pectoris

Am J Cardiol. 2020 Apr 1;125(7):1039-1045. doi: 10.1016/j.amjcard.2020.01.005. Epub 2020 Jan 8.

Abstract

Associations between elevated C-reactive protein (CRP) levels and the angina pectoris risk have been reported for many years, but the results remain controversial. To address this issue, a meta-analysis was therefore conducted. Eligible studies were identified by searching PubMed, EMBASE, Cochrane library, and web of science up to January 2019. Altogether, 10 prospective cohort studies and 11 case-control studies were included, and they were published from 1997 to 2013 and summed up to 18,316 samples totally. The pooled mean difference of CRP levels was 4.44 (95% confidence interval 2.71 to 6.17) between angina patients and healthy controls. The combined odds ratio of CRP for major adverse cardiac events in angina patients was 1.67 (95% CI 1.23 to 2.26). In conclusion, the meta-analysis indicated that elevated CRP levels were associated with angina pectoris, especially unstable angina pectoris, and were probably a risk factor of major adverse cardiac events.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Angina Pectoris / blood*
  • Angina Pectoris / epidemiology
  • Biomarkers / blood
  • C-Reactive Protein / metabolism*
  • Global Health
  • Humans
  • Incidence
  • Prognosis
  • Risk Factors
  • Survival Rate / trends

Substances

  • Biomarkers
  • C-Reactive Protein